| Ytd | 160.34% | |
| 1y | 427.05% |
| Open | 2.43 | Prev Close | 2.62 | Low | 2.38 | High | 3.09 | Mkt Cap | 321.52M |
| Vol | 16.33M | Avg Vol | 10.66M | EPS | 0.58 | P/E | 5.21 | Forward P/E | N/A |
| Beta | 0.86 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-11 | 50-d Avg | 2.22 | 200-d Avg | 1.17 | 1yr Est | 0.00 |
Rocket Lab shares fell 9.5% after Neutron’s first launch was delayed to 2027 due to manufacturing de
U.S. stocks mixed; First Tracks Biotherapeutics surged 18% on positive celiac trial results, while C
Gainers Humana (NYSE:HUM) stock moved upwards by 16.2% to $450.0 during Friday's pre-market ses
U.S. stock futures fell, with Dow futures down 450 points. Argenx sank 8.7% after a Sjögren’s trial
U.S. stock futures fell; Constellation Brands dropped 5.1% despite beating estimates, while biotech,
U.S. stock futures fell as HubSpot dropped after a downgrade; Roze AI, UMC, Quantum-Si, Intel and ot
U.S. stocks rose Friday; Applied Digital jumped 9.8% after adding 75 MW of AI capacity, while numero
U.S. stocks rose as Nasdaq gained 100+ points; HPE jumped 5.1% on stronger networking guidance and a
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
Gainers Aethlon Medical (NASDAQ:AEMD) shares rose 330.8% to $6.16 during Thursday's regular ses
Gainers DataMEDS AI (NASDAQ:MEDS) shares rose 124.1% to $3.63 during Wednesday's pre-market ses